Innovations in asthma care can improve the health of Detroiters living with this chronic disease

January 30, 2026

Medical professionals are working to transform asthma care from a reactive model that waits for symptoms to worsen into a proactive, personalized approach utilizing modern therapies. Michigan faces particularly severe asthma challenges, with Detroit ranking as the most difficult American city for asthma sufferers, experiencing rates significantly above national averages and disproportionately affecting Black residents, women, and lower-income populations. Traditional treatment methods prove insufficient because asthma manifests differently across patients, and relying on emergency care or frequent steroid use creates long-term health complications including bone loss, diabetes, and permanent lung damage.

Who is affected

Asthma patients across America (affects nearly every family)
Michigan adults (12% live with asthma)
Detroit residents (14.8% adult rate, nearly 15% childhood rate)
Black residents, women, and people with lower incomes (bearing greatest burden with higher disease rates and worse outcomes)
Detroiters experiencing frequent hospitalizations (2019-2023)
Patients with severe or hard-to-treat asthma (5-10% of asthma patients)
Patients underestimating their asthma severity (about 1 in 5)
The U.S. healthcare system ($82 billion annual cost)
University of Michigan researchers and clinicians

What action is being taken

Researchers and doctors at the University of Michigan are conducting clinical trials investigating novel therapies and forward-thinking approaches to asthma care
The author and colleagues are using personalized care plans based on mutual understanding between doctors and patients
Specialists are using new diagnostic tools such as blood tests and breath analyses to measure airway inflammation and predict flare-ups
Biologic therapies (shots administered under the skin at home) are being prescribed to carefully selected patients to control inflammation

Why it matters

This represents a critical shift from outdated reactive care that allows preventable complications to occur. The current approach leads to serious consequences: patients relying on emergency departments receive inadequate ongoing management without lung-function testing or maintenance care; just two courses of oral steroids annually increase risks of osteoporosis, diabetes, and cardiovascular disease; frequent flare-ups predict future episodes and permanent lung function loss; and even "mild" asthma can suddenly become life-threatening. Detroit's status as the most challenging place in America to live with asthma, combined with Michigan's above-average rates and stark health disparities, makes this modernization urgent. Proactive care using evidence-based practices, early risk identification, and targeted therapies can control symptoms in nearly 95% of patients with minimal medication while preventing irreversible damage, representing both a public health priority and a pathway to reducing the $82 billion annual healthcare burden.

What's next

The author advocates for adopting a proactive approach that requires addressing real-world challenges such as research gaps, costs, and access to care. While the article discusses the need for raising awareness among Michiganders, promoting evidence-based practice, and identifying at-risk people early, no explicit implementation timeline, policy changes, or concrete action steps are stated in the article.

Read full article from source: bridgedetroit.com